Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 15”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Large-scale testing (Phase 3)Study completedNCT00506415
What this trial is testing

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Who this might be right for
Alzheimer Disease
Novartis Pharmaceuticals 1,584
Not applicableWithdrawnNCT04100889
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+20 more
ProgenaBiome
Testing effectiveness (Phase 2)Study completedNCT00454870
What this trial is testing

Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Memory Pharmaceuticals 80
Post-approval studies (Phase 4)Study completedNCT00948766
What this trial is testing

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44

Who this might be right for
Alzheimer's Disease
Novartis 716
Not applicableEnded earlyNCT00548145
What this trial is testing

The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseHypercholesterolemia
Osaka University 38
Early research (Phase 1)Study completedNCT01487395
What this trial is testing

Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development

Who this might be right for
Alzheimer DiseaseBattery
University Hospital, Lille 30
Early research (Phase 1)Ended earlyNCT02288000
What this trial is testing

Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases

Who this might be right for
Alzheimer DiseaseBattery
University Hospital, Lille 30
Not applicableActive Not RecruitingNCT05637801
What this trial is testing

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more
Cognito Therapeutics, Inc. 670
Early research (Phase 1)Study completedNCT03698695
What this trial is testing

A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers

Who this might be right for
Cognitive ImpairmentAlzheimer Disease
Theranexus 152
Large-scale testing (Phase 3)Study completedNCT01689246
What this trial is testing

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 891